|
|
||||||||
From The Gertrude H. Sergievsky Center (Drs. Reitz, Luchsinger, Tang, Manly, and Mayeux), The Taub Institute for Research on Alzheimers Disease and the Aging Brain (Drs. Luchsinger, Manly, and Mayeux), The Department of Neurology (Drs. Manly and Mayeux), The Department of Medicine (Dr. Luchsinger), The Department of Psychiatry (Dr. Mayeux), The Department of Biostatistics in the Mailman School of Public Health (Dr. Tang), and The Department of Epidemiology in the Mailman School of Public Health (Dr. Mayeux), Columbia University College of Physicians and Surgeons, New York, NY.
Address correspondence and reprint requests to Dr. Richard Mayeux, Gertrude H. Sergievsky Center, 630 West 168th Street, Columbia University, New York, NY 10032; e-mail: rpm2{at}columbia.edu
Objective: To examine the association of plasma lipid levels to changes in cognitive function in elderly subjects without dementia.
Methods: The authors examined changes in performance in tests of memory, visuospatial/cognitive, and language abilities in 1,147 elderly individuals without dementia or cognitive impairment at baseline followed for 7 years using generalized estimating equations.
Results: Performance in all cognitive domains declined significantly over time, while there was no association between levels of any plasma lipid or lipid lowering treatment and memory, cognitive/visuospatial, or language performance at any interval. Higher age at baseline was related to lower scores in all three domains at each interval, while higher education and white ethnicity were associated with higher scores in all domains. Analyses relating plasma lipids to performance in color trails tests using proportional hazards regression showed no association. In subsequent analyses excluding subjects with incident dementia, memory performance declined over time, while cognitive/visuospatial and language performance did not. Higher plasma high density lipoprotein and total cholesterol were associated with higher scores in language performance at baseline; this domain declined faster among individuals with higher total cholesterol, but this result was not significant after taking multiple comparisons into account. Plasma triglycerides, low density lipoprotein, or treatment with lipid lowering agents were not associated with changes in cognitive performance.
Conclusions: Plasma lipid levels or treatment with lipid lowering agents in the elderly were not associated with changes in cognitive function.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the April 26 issue to find the title link for this article.
Supported by grants AG07232 and AG08702 from the National Institute on Aging (Bethesda, MD), the Charles S. Robertson Memorial Gift for Research in Alzheimers disease, the Blanchette Hooker Rockefeller Foundation, and the New York City Council Speakers Fund for Public Health Research (New York, NY).
Received October 15, 2004. Accepted in final form December 27, 2004.
This article has been cited by other articles:
![]() |
M. M. Mielke, Q.-L. Xue, J. Zhou, P. H. M. Chaves, L. P. Fried, and M. C. Carlson Baseline Serum Cholesterol Is Selectively Associated With Motor Speed and Not Rates of Cognitive Decline: The Women's Health and Aging Study II J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2008; 63(6): 619 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Anstey, D. M. Lipnicki, and L.-F. Low Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis Am J Geriatr Psychiatry, May 1, 2008; 16(5): 343 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Farr, K. A. Yamada, D. A. Butterfield, H. M. Abdul, L. Xu, N. E. Miller, W. A. Banks, and J. E. Morley Obesity and Hypertriglyceridemia Produce Cognitive Impairment Endocrinology, May 1, 2008; 149(5): 2628 - 2636. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |